See, W.Z.C., R. Naidu, and K.S.J.M.N. Tang. 2022. Cellular and molecular events leading to paraquat-induced apoptosis: Mechanistic insights into Parkinson’s Disease Pathophysiology. Molecular neurobiology 59(6):353–3369.
Raj, K., et al. 2021. Metals associated neurodegeneration in Parkinson’s disease: Insight to physiological, pathological mechanisms and management. Neuroscience Letters 753: 135873.
Haque, M.E., et al. 2022. Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson’s disease. British Journal of Pharmacology 179 (1): 23–45.
Teleanu, D.M., et al. 2022. An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. International Journal of Molecular Sciences 23 (11): 5938.
Article PubMed PubMed Central Google Scholar
Hernández-Pérez, O.R., et al. 2022. Biomolecules resveratrol+ coenzyme Q10 recover the cell state of human mesenchymal stem cells after 1-methyl-4-phenylpyridinium-induced damage and improve proliferation and neural differentiation. Frontiers in Neuroscience 16: 929590.
Podar, A.S., et al. 2023. An overview of analytical methods for quantitative determination of coenzyme Q10 in foods. Metabolites 13 (2): 272.
Article PubMed PubMed Central Google Scholar
Manzar, H., et al. 2020. Cellular consequences of coenzyme Q10 deficiency in neurodegeneration of the retina and brain. International Journal of Molecular Sciences 21 (23): 9299.
Watanabe, C., et al. 2023. Total and reduced/oxidized forms of coenzyme Q10 in fibroblasts of patients with mitochondrial disease. Molecular Genetics and Metabolism Reports 34: 100951.
Quagliariello, V., et al. 2020. Nano-encapsulation of coenzyme Q10 in secondary and tertiary nano-emulsions for enhanced cardioprotection and hepatoprotection in human cardiomyocytes and hepatocytes during exposure to anthracyclines and trastuzumab. International Journal of Nanomedicine 15: 4859–4876.
Suárez-Rivero, J.M., et al. 2021. Coenzyme Q10 analogues: Benefits and challenges for therapeutics. Antioxidants 10 (2): 236.
Article PubMed PubMed Central Google Scholar
Park, H.W., et al. 2020. Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson’s disease rat model. Scientific Reports 10 (1): 9572.
Pastor-Maldonado, C.J., et al. 2020. Coenzyme q10: Novel formulations and medical trends. International Journal of Molecular Sciences 21 (22): 8432.
Andra, V.V.S.N.L., et al. 2022. A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents. BioNanoScience 12 (1): 274–291.
Gitonga, F., et al. 2021. Coenzyme Q10 Ameliorates potassium cyanide-induced toxicosis in a mouse model. Scientific African 12: e00815.
Yue, T., et al. 2017. Combination of coenzyme Q10-loaded liposomes with ultrasound targeted microbubbles destruction (UTMD) for early theranostics of diabetic nephropathy. International Journal of Pharmaceutics 528 (1–2): 664–674.
Villanueva-Bermejo, D. and F.J.J.o.C.U. 2020. Temelli, Optimization of coenzyme Q10 encapsulation in liposomes using supercritical carbon dioxide. Journal of CO2 Utilization 38:68–76.
Kojima, C., et al. 2008. Preparation and characterization of complexes of liposomes with gold nanoparticles. Colloids and Surfaces B: Biointerfaces 66 (2): 246–252.
Swarnakar, N.K., et al. 2011. Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles. Biomaterials 32 (28): 6860–6874.
Shetty, A.B., et al. 2021. Novel glitazone attenuates rotenone-induced toxicity in mouse model of Parkinson’s disease. Journal of Applied Pharmaceutical Science 11 (10): 042–049.
Zhang, Y., et al. 2019. Involvement of Akt/mTOR in the neurotoxicity of rotenone-induced Parkinson’s disease models. International Journal of Environmental Research and Public Health 16 (20): 3811.
Elmorsy, E., et al. 2021. The protective effect of Indian Catechu methanolic extract against aluminum chloride-induced neurotoxicity, A rodent model of Alzheimer’s disease. Heliyon 7 (2): e06269.
Yan, A, et al. 2019. Idebenone alleviates neuroinflammation and modulates microglial polarization in LPS-stimulated BV2 cells and MPTP-induced Parkinson’s disease mice. Frontiers in Cellular Neuroscience 12:529.
Abu-Elfotuh, K., et al. 2022. Neuroprotective Effects of Some Nutraceuticals against Manganese-Induced Parkinson’s Disease in Rats: Possible Modulatory Effects on TLR4/NLRP3/NF-κB, GSK-3β, Nrf2/HO-1, and Apoptotic Pathways. Pharmaceuticals 15 (12): 1554.
Sikorska, M., et al. 2014. Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson’s disease. Neurobiology of Aging 35 (10): 2329–2346.
Mir, N.T., et al. 2019. Lawsonia Inermis markedly improves cognitive functions in animal models and modulate oxidative stress markers in the brain. Medicina 55 (5): 192.
Article PubMed PubMed Central Google Scholar
Iqbal, A., et al. 2022. Inhibition of oxidative stress and the nf-κb pathway by a vitamin e derivative: pharmacological approach against parkinson’s disease. ACS Omega 7 (49): 45088–45095.
Article PubMed PubMed Central Google Scholar
Hira, S., et al. 2020. In silico study and pharmacological evaluation of Eplerinone as an Anti-Alzheimer’s drug in STZ-induced Alzheimer’s disease model. ACS Omega 5 (23): 13973–13983.
Bhangale, J.O., S.R.J.A.I.P. Acharya, and P. Sciences. 2016. Anti-Parkinson activity of petroleum ether extract of Ficus religiosa (L.) leaves. Advances in Pharmacological Sciences 2016 (1): 9436106.
PubMed PubMed Central Google Scholar
Anwar, F., et al. 2021. Toxicity evaluation of the naphthalen-2-yl 3, 5-dinitrobenzoate: A drug candidate for alzheimer disease. Frontiers in Pharmacology 12: 607026.
Article PubMed PubMed Central Google Scholar
Khatri, D.K., and A.R.J.P.B. Juvekar. 2016. Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson’s disease. Pharmacology Biochemistry and Behavior 150: 39–47.
Bhangale, J.O., and S.R.J.A.i.P. Acharya. 2016. Anti-Parkinson activity of petroleum ether extract of Ficus religiosa (L) leaves. Advances in Pharmacological and Pharmaceutical Sciences 9436106
Bais, S., N. Gill, and N.J.C.J.O.B. Kumar. 2015. Neuroprotective effect of Juniperus communis on chlorpromazine induced Parkinson disease in animal model. Chinese Journal of Biology 2015 (1): 7.
Waterborg, J.H. (2009). The lowry method for protein quantitation. In: Walker, J.M. (eds) The Protein Protocols Handbook. Springer Protocols Handbooks. Humana Press, Totowa, NJ.
Nazir, S., et al. 2021. Drotaverine inhibitor of PDE4: Reverses the streptozotocin induced alzheimer’s disease in mice. Neurochemical Research 46: 1814–1829.
Pawar, R., et al. 2020. Phytochemical screening, characterization of bioactive component of plant phragmites karka (retz.) trin ex steud with wound healing activity. Environmental Science and Pollution Research 1 (2): 14.
Asghar, A., et al. 2023. Ficus johannis Boiss. leaves ethanolic extract ameliorate streptozotocin-induced diabetes in rats by upregulating the expressions of GCK, GLUT4, and IGF and downregulating G6P. p. 1–17. Environmental Science and Pollution Research 30, 49108–49124
Akhtar, M.F, et al. 2021. Attenuating effect of Prosopis cineraria against paraquat-induced toxicity in prepubertal mice, Mus musculus. p. 1–17.
Talpate, K.A., et al. 2014. Neuroprotective and nootropic activity of Clitorea ternatea Linn. (Fabaceae) leaves on diabetes induced cognitive decline in experimental animals. Journal of Pharmacy and Bioallied Sciences 6 (1): 48.
Bano, S., et al. 2023. Mechanistic insights on the possible protective role of polyphenols extracted from Tamarix aphylla aerial parts against sodium arsenite-induced hepatotoxicity in rats. Environmental Science and Pollution Research 30 (6): 16565–16578.
Hu, Q., et al. 2016. Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson’s disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1862 (10): 1883–1890.
Thomas Broome, S., and A.J.I.J.O.M.S. Castorina. 2022. The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences 23 (3): 1845.
Alharbi, M., et al. 2022. Effect of natural adenylcyclase/cAMP/CREB signalling activator forskolin against intra-striatal 6-OHDA-lesioned Parkinson’s rats: preventing mitochondrial, motor and histopathological defects. Molecules 27 (22): 7951.
留言 (0)